Q2 2026 13F filing
Updated 28 days ago129 disclosed positions worth $5.4B
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E EWTX EDGEWISE THERAPEUTICS INC | $630.5M | 15.52M | 11.68% | Unchanged |
| 2 | E ELVN ENLIVEN THERAPEUTICS INC | $343.9M | 6.78M | 6.37% | Trimmed(-14.9%) |
| 3 | L LLY ELI LILLY & CO | $309.3M | 257.9K | 5.73% | Added(+8.9%) |
| 4 | M MBX MBX BIOSCIENCES INC | $189.3M | 3.43M | 3.51% | Trimmed(-5.8%) |
| 5 | S SVA SINOVAC BIOTECH LTD | $184.5M | 2.72M | 3.42% | Unchanged |
| 6 | A AZN ASTRAZENECA PLC | $171.1M | 915.7K | 3.17% | Added(+36.6%) |
| 7 | G GPCR STRUCTURE THERAPEUTICS INC | $118.6M | 2.21M | 2.20% | Added(+49.8%) |
| 8 | S SION SIONNA THERAPEUTICS INC | $112.4M | 2.56M | 2.08% | Trimmed(-27.6%) |
| 9 | C CRVS CORVUS PHARMACEUTICALS INC | $107M | 7.17M | 1.98% | Unchanged |
| 10 | ? N/A ARRIVENT BIOPHARMA INC | $105.2M | 3.03M | 1.95% | Unchanged |
| 11 | G GH GUARDANT HEALTH INC | $87.6M | 583.7K | 1.62% | Added(+34.1%) |
| 12 | A ARGX ARGENX SE | $86.2M | 92.9K | 1.60% | Trimmed(-32.1%) |
| 13 | M MRK MERCK & CO INC | $85.2M | 663.4K | 1.58% | Unchanged |
| 14 | Q QURE UNIQURE NV | $83.3M | 1.81M | 1.54% | Trimmed(-15.4%) |
| 15 | P PRAX PRAXIS PRECISION MEDICINES I | $77M | 230.1K | 1.43% | Added(+33.4%) |
| 16 | E EW EDWARDS LIFESCIENCES CORP | $75.5M | 834.9K | 1.40% | Trimmed(-32.2%) |
| 17 | P PRLD PRELUDE THERAPEUTICS INC | $73.2M | 13.72M | 1.36% | Added(+25.8%) |
| 18 | A AAVXF ABIVAX SA | $72.8M | 546.5K | 1.35% | Added(+17.4%) |
| 19 | D DYN DYNE THERAPEUTICS INC | $71.9M | 3.24M | 1.33% | Added(+10.9%) |
| 20 | N NTRA NATERA INC | $71.1M | 262.0K | 1.32% | Unchanged |
| 21 | C CGON CG ONCOLOGY INC | $69.1M | 972.8K | 1.28% | Added(+2.6%) |
| 22 | U UNH UNITEDHEALTH GROUP INC | $67M | 161.1K | 1.24% | — |
| 23 | S SVM ARS PHARMACEUTICALS INC | $66.4M | 8.29M | 1.23% | Unchanged |
| 24 | A ASND ASCENDIS PHARMA A/S | $65.2M | 244.5K | 1.21% | — |
| 25 | H HUM HUMANA INC | $65.2M | 164.1K | 1.21% | — |
| 26 | C COGT COGENT BIOSCIENCES INC | $65.1M | 1.68M | 1.21% | Added(+422.0%) |
| 27 | B BSX BOSTON SCIENTIFIC CORP | $63.3M | 1.48M | 1.17% | Trimmed(-37.7%) |
| 28 | I ISRG INTUITIVE SURGICAL INC | $62.8M | 157.9K | 1.16% | Trimmed(-24.3%) |
| 29 | M MLYS MINERALYS THERAPEUTICS INC | $56.9M | 2.11M | 1.05% | Added(+2.8%) |
| 30 | O ODTX ODYSSEY THERAPEUTICS INC | $56.2M | 3.00M | 1.04% | — |
| 31 | X XENE XENON PHARMACEUTICALS INC | $53.9M | 892.5K | 1.00% | Trimmed(-15.8%) |
| 32 | A ARQT ARCUTIS BIOTHERAPEUTICS INC | $53.5M | 2.04M | 0.99% | — |
| 33 | C CELG-RI BRISTOL-MYERS SQUIBB CO | $53.3M | 925.0K | 0.99% | Unchanged |
| 34 | Q QTTB Q32 BIO INC | $52.6M | 4.13M | 0.97% | Added(+83.2%) |
| 35 | S SYK STRYKER CORPORATION | $50.1M | 159.1K | 0.93% | Trimmed(-12.8%) |
| 36 | C CAI CARIS LIFE SCIENCES INC | $50M | 2.81M | 0.93% | Unchanged |
| 37 | S STT-PG SPDR SERIES TRUST | $47.5M | 300.0K | 0.88% | — |
| 38 | T TMO THERMO FISHER SCIENTIFIC INC | $45.5M | 90.7K | 0.84% | Added(+95.0%) |
| 39 | P PVLA PALVELLA THERAPEUTICS INC NE | $44.7M | 292.4K | 0.83% | Added(+484.7%) |
| 40 | E ELV ELEVANCE HEALTH INC FORMERLY | $44.4M | 114.7K | 0.82% | Unchanged |
| 41 | S STTK SHATTUCK LABS INC | $43.8M | 6.31M | 0.81% | Unchanged |
| 42 | ? N/A UPSTREAM BIO INC | $39.4M | 5.69M | 0.73% | Unchanged |
| 43 | C CRNX CRINETICS PHARMACEUTICALS IN | $37.4M | 999.0K | 0.69% | Unchanged |
| 44 | R RYTM RHYTHM PHARMACEUTICALS INC | $35.9M | 322.9K | 0.66% | Added(+2.8%) |
| 45 | S SNDX SYNDAX PHARMACEUTICALS INC | $33.7M | 1.54M | 0.62% | Added(+60.2%) |
| 46 | F FBRX FORTE BIOSCIENCES INC | $33.5M | 1.58M | 0.62% | Added(+31.8%) |
| 47 | ? N/A COMPASS THERAPEUTICS INC | $33.3M | 15.22M | 0.62% | Unchanged |
| 48 | N NKTR NEKTAR THERAPEUTICS | $32.5M | 465.3K | 0.60% | Added(+69.2%) |
| 49 | K KRYS KRYSTAL BIOTECH INC | $30.9M | 83.2K | 0.57% | Added(+20.4%) |
| 50 | F FERG PRELUDE THERAPEUTICS INC | $30.3M | 5.68M | 0.56% | Unchanged |